DinalineAlternative Names: AAPBA; GOE 1734; NSC 328786; PD 104208
Latest Information Update: 30 Jul 1998
At a glance
- Originator Goedecke
- Developer Goedecke; Nonindustrial source
- Class Aniline compounds; Antineoplastics; Small molecules
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Cancer